about
MicroRNA-145 regulates human corneal epithelial differentiationAnaesthesia for patients with a transplanted organ.Allergic conjunctivitis exacerbates corneal allograft rejection by activating Th1 and th2 alloimmune responses.Gene therapeutic approaches to induction and maintenance of tolerance.Two different regulatory T cell populations that promote corneal allograft survival.A novel function for programmed death ligand-1 regulation of angiogenesisCell death and immune privilege.High-risk corneal allografts and why they lose their immune privilege.IL-17 promotes immune privilege of corneal allograftsNeutralization of mouse interleukin-17 bioactivity inhibits corneal allograft rejection.The immune privilege of corneal grafts.Corneal immunity is mediated by heterogeneous population of antigen-presenting cells.Influence of HLA-A, HLA-B, and HLA-DR matching on rejection of random corneal grafts using corneal tissue for retrospective DNA HLA typing.Effects of Detergent-Based Protocols on Decellularization of Corneas With Sclerocorneal Limbus. Evaluation of Regional Differences.Tolerance and autoimmunity in the eye: a role for CD8 T cells in organ-specific autoimmunity in the retina.Quantitative evaluation of the corneal endothelium in the mouse after grafting.Corneal transplantation: the forgotten graft.Gene therapy approaches to prolonging corneal allograft survival.Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.The chemokine receptor CX3CR1 mediates homing of MHC class II-positive cells to the normal mouse corneal epithelium.Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).Azithromycin treatment increases survival of high-risk corneal allotransplants.Immune mechanisms of corneal allograft rejection.Oligopeptide-mediated gene transfer into mouse corneal endothelial cells: expression, design optimization, uptake mechanism and nuclear localization.One-year follow-up of epithelial corneal cell sheet allografts mounted on platelet poor plasma in rabbits.Effect of Corneal Nerve Ablation on Immune Tolerance Induced by Corneal Allografts, Oral Immunization, or Anterior Chamber Injection of Antigens.Immune privilege of corneal allografts.Xenotransplantation--the future of corneal transplantation?Tacrolimus in the treatment of ocular diseases.Cornea: Window to Ocular Immunology.A comparison of three methods of decellularization of pig corneas to reduce immunogenicity.Corneal grafting for the treatment of full-thickness corneal defects in dogs: a review of 50 cases.Wound-Healing Studies in Cornea and Skin: Parallels, Differences and Opportunities.Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival.Murine corneal stroma cells inhibit LPS-induced dendritic cell maturation partially through TGF-β2 secretion in vitro.Quantification of allospecific and nonspecific corneal endothelial cell damage after corneal transplantation.Clinical transplantation of individualized recipient serum-adapted cornea reduces the risk of graft rejection after keratoplasty.Corneal graft rejection is accompanied by apoptosis of the endothelium and is prevented by gene therapy with bcl-xL.Gene Therapy for Modulation of T-Cell-Mediated Immune Response Provoked by Corneal Transplantation.Effects of CD25siRNA gene transfer on high-risk rat corneal graft rejection.
P2860
Q33942035-E35D79CF-A03D-4534-BA3D-A118CB58F820Q34001023-B005E892-9940-45CD-9149-396C9B4C23B6Q34023710-9180E7D7-DA7D-4ABA-B578-0410773BC3F9Q34560532-78169AC5-6EEB-4648-A7F9-27FC7D727EBBQ34662264-1A58EE0F-B8D8-4AF8-BDE5-89B44998C007Q34805624-69B4F1BD-EE79-4A4F-A37B-664D959E7B03Q34993208-26F77C65-F5BB-48D2-BCB3-BE90DCD8AFB2Q35048752-1C57EF65-EF7E-4133-AA84-155D3CAAA28FQ35095350-036DE1DE-9AFE-4702-B999-376480A37855Q35166622-CF9D3F50-B492-482A-BD81-78DD9123169AQ35186805-AC4C3121-9449-426D-A7F3-6D45D46226AEQ35186808-34C770DF-23AF-44F8-A673-BB3873783387Q35317808-9B4F98A8-FBFE-496F-A65C-97BBF8580D6BQ35508072-B37C7E3A-F2D7-4115-9E96-FCC359AF0DBCQ35591041-D398A691-52A2-4F01-A0B8-87AEDE162EFAQ35592428-55F00E62-D1CA-481C-8E83-F780BD1C4E8FQ35745697-D7A52341-09D9-4BE3-A516-8E6EB053F73FQ35842657-270930BD-8B8F-4119-9B5E-4F3E7CA2B4F0Q35921437-210AAFDA-CF34-4FE7-A86F-A6692FF0567BQ36083323-B92603FD-A572-4FEE-9D78-BF57E2D2B3C5Q36481782-5348FA9D-0605-497E-833B-1481A3DC5030Q36755971-C7648101-1AF9-4BAE-A233-225DCCD6E97AQ37034304-24A884AE-A832-4F46-95FB-F4404B3BA6A6Q37393524-A084F6A3-A85B-4AAF-A6E3-4DD04E11AF1BQ37476783-D2A7CC36-328D-4527-B417-5AF7099E37E2Q37583275-737AC663-BBD9-40F4-A828-D292BE3D0CE6Q37756164-6BDC4BDF-2E36-470B-BADA-DF4A2D67AF1BQ37811749-A50A1E57-8476-4B00-A476-9ED544DD281AQ37858514-E47DD1C8-9D3E-41EC-ACA6-423B78A94D60Q37905546-1702B1F9-7855-4F27-A92B-E155605E8674Q38304660-5376F1D4-9D1D-425B-9024-94D3D5D1AA04Q38848518-229C2B89-2164-4550-9056-A472BAFAAE43Q39366645-5FE04DEB-B67B-4499-ABA4-84722C4E399EQ41765008-CCC35704-23BF-4E2B-B0BC-5E1A4C65E248Q41958029-B9FDEC1B-604C-487D-B121-9600BA879526Q43100284-4DDE33EC-65C6-486F-B4DD-E4AA810EB280Q43480440-01368E7C-88EE-437F-8B14-A748C942544CQ45869400-A558B353-A12D-4A81-9FF9-D27C82559EB5Q45872942-5C173864-F19F-41C8-B6B3-8FF9DB744FE6Q45876389-D923C9D7-6404-4EE7-9A45-8151964601DD
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The immune privilege of corneal allografts.
@ast
The immune privilege of corneal allografts.
@en
type
label
The immune privilege of corneal allografts.
@ast
The immune privilege of corneal allografts.
@en
prefLabel
The immune privilege of corneal allografts.
@ast
The immune privilege of corneal allografts.
@en
P1433
P1476
The immune privilege of corneal allografts.
@en
P2093
Niederkorn JY
P304
P356
10.1097/00007890-199906270-00001
P577
1999-06-01T00:00:00Z